BBNXBeta Bionics, Inc.
$17.44-21% 1Y
$17.44
$8.8652 weeks$31.99
Is the price fair?
What BBNX's price assumes
Beta Bionics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 4.05× revenue.
4.05
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 1.65
Price / book · as of 2026-Q1
- EV / sales
- 3.84
EV / sales
Details›
- Price / bookas of 2026-Q1
- 1.65
- EV / EBIToperating margin −70%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 3.84
- Market capitalisation
- $777M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
The closest names by size in the same industry